What sedatives are used for sleep disturbances in patients with dementia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Sedatives for sleep disturbances in dementia patients should be used with caution, and the choice of medication depends on the patient's underlying disease and symptoms.

  • For patients with dementia, clonazepam can be used in lower doses, starting at 0.25 mg, but its use is often limited due to concerns about morning sedation, gait imbalance, and cognitive disturbances 1.
  • Melatonin is a mildly sedating option, with dosing starting at 3 mg and increasing by 3-mg increments to 15 mg, and is often considered for older patients (> 50 years old) and those with neurodegenerative disease 1.
  • Rivastigmine, an acetylcholinesterase inhibitor, may be an appropriate choice for patients with dementia and sleep disturbances, particularly those with cognitive impairment refractory to other treatments, but its use may be associated with excessive daytime sleepiness 1. When choosing a medication, clinicians should consider the patient's underlying disease and attendant symptoms, and non-pharmacological approaches should always be the first line of treatment.

From the Research

Sedatives Used for Sleep Disturbances in Patients with Dementia

  • The following sedatives have been studied for their effectiveness in treating sleep disturbances in patients with dementia:
    • Melatonin: There is low-certainty evidence that melatonin doses up to 10 mg may have little or no effect on any major sleep outcome over eight to 10 weeks in people with Alzheimer's disease and sleep disturbances 2, 3.
    • Trazodone: There is low-certainty evidence that trazodone 50 mg may improve total nocturnal sleep time and sleep efficiency in people with moderate-to-severe Alzheimer's disease 2, 3.
    • Ramelteon: There is low-certainty evidence that ramelteon 8 mg may have no effect on total nocturnal sleep time in people with mild-to-moderate Alzheimer's disease 2, 3.
    • Orexin antagonists: There is moderate-certainty evidence that an orexin antagonist may increase total nocturnal sleep time and decrease time awake after sleep onset in people with mild-to-moderate Alzheimer's disease 2.
  • Other treatments that may be used to help manage sleep disturbances in patients with dementia include:
    • Light therapy: Bright light therapy may be used to help regulate the sleep-wake cycle in patients with dementia 4, 5.
    • Non-pharmacological interventions: Non-pharmacological interventions such as physical and social activities, carer interventions, and multimodal interventions may be used to help improve sleep in patients with dementia 6.
    • Cognitive-behavioral therapy for insomnia: This type of therapy may be used to help treat chronic insomnia in patients with neurocognitive disorders 5.

Adverse Effects of Sedatives

  • The adverse effects of sedatives used to treat sleep disturbances in patients with dementia are not well studied, but may include:
    • Increased risk of falls and cognitive impairment 2, 3.
    • Sedation and daytime sleepiness 2, 3.
  • It is essential to systematically assess adverse effects in future trials of sedatives for sleep disturbances in patients with dementia 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacotherapies for sleep disturbances in dementia.

The Cochrane database of systematic reviews, 2020

Research

Pharmacotherapies for sleep disturbances in dementia.

The Cochrane database of systematic reviews, 2016

Research

Treatment of Sleep Disorders in Dementia.

Current treatment options in neurology, 2016

Research

Non-pharmacological interventions for sleep disturbances in people with dementia.

The Cochrane database of systematic reviews, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.